Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stem cell therapy for cerebral palsy.

John Bartley1, James E Carroll

  • 1Department of Pediatrics of the Medical College of Georgia, Augusta, Georgia, USA.

Expert Opinion on Biological Therapy
|July 2, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

One pot synthesis of furan-modified lignin from agricultural waste via lignin-first approach.

Bioresource technology·2024
Same author

Correction: Perforated peptic ulcer disease in transferred patients is associated with significant increase in length of stay.

Surgical endoscopy·2024
Same author

Perforated peptic ulcer disease in transferred patients is associated with significant increase in length of stay.

Surgical endoscopy·2024
Same author

Closing the loop: Valorizing pyrolyzed waste tyre residue into functional carbon materials, SiO<sub>2</sub> with exceptionally high silanol groups, and Zn salt.

Waste management (New York, N.Y.)·2022
Same author

Does increasing insurance improve outcomes for US cancer patients?

The Journal of surgical research·2013
Same author

Perioperative mortality after pancreatectomy: a risk score to aid decision-making.

Surgery·2012
Same journal

Biologic modulation of ineffective erythropoiesis in thalassemia: mechanisms, clinical practice, and future targets.

Expert opinion on biological therapy·2026
Same journal

TNF inhibitors for the long-term management of juvenile idiopathic arthritis associated uveitis: real-life data from the ITHACA cohort.

Expert opinion on biological therapy·2026
Same journal

Type 2 inflammation and biologics: a twenty-year journey.

Expert opinion on biological therapy·2026
Same journal

Current outlook on the use of biological agents to improve outcomes in adult secondary hemophagocytic lymphohistiocytosis.

Expert opinion on biological therapy·2026
Same journal

Addressing challenges in disease management of childhood-onset systemic lupus erythematosus: the role of biologics, with primary focus on rituximab and belimumab.

Expert opinion on biological therapy·2026
Same journal

Biological drugs for the treatment of children with atopic dermatitis.

Expert opinion on biological therapy·2026
See all related articles

Stem cell therapy shows promise for treating cerebral palsy (CP), a chronic childhood motor disability. Animal studies suggest intravascular transplantation is feasible, paving the way for human trials.

Area of Science:

  • Neurology
  • Regenerative Medicine
  • Pediatrics

Background:

  • Cerebral palsy (CP) encompasses chronic motor disabilities in children, stemming from diverse causes including developmental abnormalities and birth-related injuries.
  • The incidence of CP may be rising due to increased survival rates of very premature infants.
  • Neonatal hypoxic-ischaemic (HI) injury in infants, though a minority cause of CP, significantly impacts oligodendrocytes and cerebral white matter.

Purpose of the Study:

  • To explore the potential of stem cell therapy for cerebral palsy (CP).
  • To evaluate the feasibility of intravascular stem cell transplantation for neurological disorders.
  • To identify key variables for future human clinical trials in CP.

Main Methods:

  • Review of existing literature on stem cell therapy in neurological disorders.

Related Experiment Videos

  • Analysis of animal studies involving experimentally induced strokes and traumatic brain injuries.
  • Consideration of variables for human trials, including cell type, transplant timing, and functional outcomes.

    • Main Results:

    • Stem cell therapy presents a promising avenue for CP treatment.
    • Animal models with induced injuries indicate potential therapeutic benefits from stem cells.
    • Intravascular transplantation offers a less invasive delivery method compared to direct brain injection.

    Conclusions:

    • While no controlled human trials for CP exist, animal data supports further investigation.
    • Systematic studies in animal models of HI injury are crucial for optimizing stem cell therapy.
    • The findings support the translation of intravascular stem cell transplantation to human trials for cerebral palsy.